BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9721209)

  • 1. Characterization of the human dihydropyrimidine dehydrogenase gene.
    Wei X; Elizondo G; Sapone A; McLeod HL; Raunio H; Fernandez-Salguero P; Gonzalez FJ
    Genomics; 1998 Aug; 51(3):391-400. PubMed ID: 9721209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural organization of the human dihydropyrimidine dehydrogenase gene.
    Johnson MR; Wang K; Tillmanns S; Albin N; Diasio RB
    Cancer Res; 1997 May; 57(9):1660-3. PubMed ID: 9135003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-throughput denaturing high-performance liquid chromatography method for the identification of variant alleles associated with dihydropyrimidine dehydrogenase deficiency.
    Ezzeldin H; Okamoto Y; Johnson MR; Diasio RB
    Anal Biochem; 2002 Jul; 306(1):63-73. PubMed ID: 12069415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profound dihydropyrimidine dehydrogenase deficiency resulting from a novel compound heterozygote genotype.
    Johnson MR; Wang K; Diasio RB
    Clin Cancer Res; 2002 Mar; 8(3):768-74. PubMed ID: 11895907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene.
    van Kuilenburg AB; Haasjes J; Richel DJ; Zoetekouw L; Van Lenthe H; De Abreu RA; Maring JG; Vreken P; van Gennip AH
    Clin Cancer Res; 2000 Dec; 6(12):4705-12. PubMed ID: 11156223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared with controls.
    Raida M; Schwabe W; Häusler P; Van Kuilenburg AB; Van Gennip AH; Behnke D; Höffken K
    Clin Cancer Res; 2001 Sep; 7(9):2832-9. PubMed ID: 11555601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Known variant DPYD alleles do not explain DPD deficiency in cancer patients.
    Collie-Duguid ES; Etienne MC; Milano G; McLeod HL
    Pharmacogenetics; 2000 Apr; 10(3):217-23. PubMed ID: 10803677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of dihydropyrimidine dehydrogenase deficiency in a neonate with thymine-uraciluria.
    Au KM; Lai CK; Yuen YP; Shek CC; Lam CW; Chan AY
    Hong Kong Med J; 2003 Apr; 9(2):130-2. PubMed ID: 12668826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of three novel mutations in the dihydropyrimidine dehydrogenase gene associated with altered pre-mRNA splicing or protein function.
    Van Kuilenburg AB; Meinsma R; Beke E; Bobba B; Boffi P; Enns GM; Witt DR; Dobritzsch D
    Biol Chem; 2005 Apr; 386(4):319-24. PubMed ID: 15899693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lethal outcome of a patient with a complete dihydropyrimidine dehydrogenase (DPD) deficiency after administration of 5-fluorouracil: frequency of the common IVS14+1G>A mutation causing DPD deficiency.
    van Kuilenburg AB; Muller EW; Haasjes J; Meinsma R; Zoetekouw L; Waterham HR; Baas F; Richel DJ; van Gennip AH
    Clin Cancer Res; 2001 May; 7(5):1149-53. PubMed ID: 11350878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel mutation in the dihydropyrimidine dehydrogenase gene in a patient with a lethal outcome following 5-fluorouracil administration and the determination of its frequency in a population of 500 patients with colorectal carcinoma.
    Morel A; Boisdron-Celle M; Fey L; Lainé-Cessac P; Gamelin E
    Clin Biochem; 2007 Jan; 40(1-2):11-7. PubMed ID: 17046731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the human dihydropyrimidine dehydrogenase gene by denaturing high-performance liquid chromatography.
    Fischer J; Schwab M; Eichelbaum M; Zanger UM
    Genet Test; 2003; 7(2):97-105. PubMed ID: 12885330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity.
    Wei X; McLeod HL; McMurrough J; Gonzalez FJ; Fernandez-Salguero P
    J Clin Invest; 1996 Aug; 98(3):610-5. PubMed ID: 8698850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational spectrum of dihydropyrimidine dehydrogenase gene (DPYD) in the Tunisian population.
    Ben Fredj R; Gross E; Chouchen L; B'Chir F; Ben Ahmed S; Neubauer S; Kiechle M; Saguem S
    C R Biol; 2007 Oct; 330(10):764-9. PubMed ID: 17905396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of correlation between phenotype and genotype for the polymorphically expressed dihydropyrimidine dehydrogenase in a family of Pakistani origin.
    Fernandez-Salguero PM; Sapone A; Wei X; Holt JR; Jones S; Idle JR; Gonzalez FJ
    Pharmacogenetics; 1997 Apr; 7(2):161-3. PubMed ID: 9170156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FRA1E common fragile site breaks map within a 370kilobase pair region and disrupt the dihydropyrimidine dehydrogenase gene (DPYD).
    Hormozian F; Schmitt JG; Sagulenko E; Schwab M; Savelyeva L
    Cancer Lett; 2007 Feb; 246(1-2):82-91. PubMed ID: 16556484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput genotyping by DHPLC of the dihydropyrimidine dehydrogenase gene implicated in (fluoro)pyrimidine catabolism.
    Gross E; Seck K; Neubauer S; Mayr J; Hellebrand H; Ratanaphan A; Lutz V; Stockinger H; Kiechle M
    Int J Oncol; 2003 Feb; 22(2):325-32. PubMed ID: 12527930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of the DPYD promoter: an alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patients.
    Ezzeldin HH; Lee AM; Mattison LK; Diasio RB
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8699-705. PubMed ID: 16361556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and initial characterization of the human DPYD gene promoter.
    Collie-Duguid ES; Johnston SJ; Powrie RH; Milano G; Etienne MC; Rochat B; Watson GC; McLeod HL
    Biochem Biophys Res Commun; 2000 Apr; 271(1):28-35. PubMed ID: 10777676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human polymorphism in drug metabolism: mutation in the dihydropyrimidine dehydrogenase gene results in exon skipping and thymine uracilurea.
    Meinsma R; Fernandez-Salguero P; Van Kuilenburg AB; Van Gennip AH; Gonzalez FJ
    DNA Cell Biol; 1995 Jan; 14(1):1-6. PubMed ID: 7832988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.